AbbVie said it has reached an agreement with Amgen in an intellectual property dispute regarding AbbVie's Humira (adalimumab).

Patients in Japan with hepatitis C virus (HCV) infection have a new eight-week treatment available now that the Japanese Ministry of Health, Labour and Welfare has approved Maviret (glecaprevir/pibrentasvir), AbbVie said in a release.

Adults with diabetes can now use Abbott’s breakthrough FreeStyle Libre Flash glucose monitoring system thanks to recent U.S. Food and Drug Administration (FDA) approval.

Merck executives will conduct a live sales and earnings conference call for its investors and analysts at 8 a.m. Oct. 27.

An Interpol-managed global crackdown on online sellers of illicit prescription drugs has led to approximately 400 arrests worldwide and the seizure of more than $51 million worth of potentially dangerous medicines.

A European regulatory panel recently issued a positive opinion recommending marketing authorization for guselkumab for the treatment of moderate to severe plaque psoriasis in the European Union.

Bristol-Myers Squibb said its Opdivo (nivolumab) recently gained endorsement from Japan’s Ministry of Health, Labor and Welfare (MHLW) as the first immuno-oncology approved regimen for treating advanced gastric cancer.

The House Ways and Means recently approved three pieces of bipartisan legislation geared toward improving the Medicare program, a committee release said.

Trelegy Ellipta, an inhalation treatment, has received Food and Drug Administration approval for once-a-day use as a maintenance medication for U.S. patients.

A European panel has recommended approval of a self-injectable reformulated version of Benlysta (belimumab) as an adjunct therapy for certain adults with systemic lupus erythematosus (SLE).

GlaxoSmithKline (GSK) said its Shingrix vaccine, indicated for the prevention of herpes zoster (commonly known as shingles) in older adults, recently attained unanimous preliminary approval from a U.S. Food and Drug Administration (FDA) advisory committee.

Merck recently announced that the European Commission has approved Keytruda as an antibody treatment for advanced bladder cancer in the European Union (EU).

The Food and Drug Administration (FDA) recently announced its first-ever approved gene therapy in the United States, an article posted on the National Organization for Rare Disorders website said.

The Food and Drug Administration has given Pfizer's Besponsa the go-ahead to be used by adults who have relapsed or refractory B-cell precursor acute lymphoblastic leukemia.

Medical experts at Houston Methodist Hospital are working to develop a blood test that will tell them which people fighting breast cancer face a higher chance of developing brain cancer.

Sucampo Pharmaceuticals said a Phase 1/2a study of its experimental drug VTS-270 (2-hydroxypropyl-beta-cyclodextrin) injected into the spinal theca indicated the drug can slow the symptoms of the progression of Niemann-Pick Disease Type C1 (NPC-1).

The Food and Drug Administration gave Imbruvica the go-ahead to be used to fight chronic graft versus host disease (GVHD) after one or more treatments aimed at fighting disease have not worked.

The U.S. House Energy and Commerce Committee recently advanced a proposed law that would update how Americans get their drinking water.

Vifor Pharma recently said it began three new tests for Ferinject (ferric carboxymaltose), its intravenous iron replacement therapy for patients with systolic heart failure and iron deficiency.

Puma Biotechnology has hit its goal in terms of how many people it has signed up for a Phase III test of PB272 (neratinib) to fight breast cancer.